0517-2901-01 : NDC 2026 Code

0517-2901-01 : Glucagon Injection ( Gvoke Vialdx )

Additionally :

You can get information about “0517-2901-01” NDC code in 0517-2901-01 in HTML format

HTML | 0517-2901-01 in TXT (Plain Text) format

TXT | 0517-2901-01 in PDF (Portable Document Format)

PDF | 0517-2901-01 in XML format

XML formats.

NDC Code : 0517-2901-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0517-2901-01",
    "PackageDescription": "1 VIAL in 1 CARTON (0517-2901-01)  / .2 mL in 1 VIAL",
    "NDC11Code": "00517-2901-01",
    "ProductNDC": "0517-2901",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Gvoke Vialdx",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Glucagon Injection",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20250819",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA212097",
    "LabelerName": "American Regent, Inc.",
    "SubstanceName": "GLUCAGON",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/.2mL",
    "Pharm_Classes": "Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-08-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250819",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}